Title
Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation
Date Issued
15 October 2021
Access level
open access
Resource Type
journal article
Author(s)
Bravo M.S.
Nicolás D.
Berengua C.
Fernandez M.
Tortajada M.
Barroso S.
Vilella A.
Mosquera M.M.
Vila J.
Marcos M.A.
Hospital Clínico de Barcelona
Publisher(s)
Oxford University Press
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) provides a highly variable cycle threshold (Ct) value that cannot distinguish viral infectivity. Subgenomic ribonucleic acid (sgRNA) has been used to monitor active replication. Given the importance of long RT-PCR positivity and the need for work reincorporation and discontinuing isolation, we studied the functionality of normalized viral loads (NVLs) for patient monitoring and sgRNA for viral infectivity detection. Methods: The NVLs measured through the Nucleocapsid and RNA-dependent-RNA-polymerase genes and sgRNA RT-PCRs were performed in 2 consecutive swabs from 84 healthcare workers. Results: The NVLs provided similar and accurate quantities of both genes of SARS-CoV-2 at 2 different timepoints of infection, overcoming Ct-value and swab collection variability. Among SARS-CoV-2-positive samples, 51.19% were sgRNA-positive in the 1st RT-PCR and 5.95% in the 2nd RT-PCR. All sgRNA-positive samples had >4 log10 RNA copies/1000 cells, whereas samples with ≤1 log10 NVLs were sgRNA-negative. Although NVLs were positive until 29 days after symptom onset, 84.1% of sgRNA-positive samples were from the first 7 days, which correlated with viral culture viability. Multivariate analyses showed that sgRNA, NVLs, and days of symptoms were significantly associated (P<.001). Conclusions: The NVLs and sgRNA are 2 rapid accessible techniques that could be easily implemented in routine hospital practice providing a useful proxy for viral infectivity and coronavirus disease 2019 patient follow-up.
Start page
1325
End page
1332
Volume
224
Issue
8
Language
English
OCDE Knowledge area
Enfermedades infecciosas Sistema respiratorio Biología celular, Microbiología Políticas de salud, Servicios de salud
Scopus EID
2-s2.0-85119474300
PubMed ID
Source
Journal of Infectious Diseases
ISSN of the container
00221899
Sources of information: Directorio de Producción Científica Scopus